Explore new strategies for treating resistant lung cancer. Discover how blocking growth hormone receptors may improve ...

FDA expands Sogroya approval for pediatric patients with Noonan syndrome, idiopathic short stature, and those born small for gestational age.

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments.

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...

Ohio University researchers have discovered what may be a new way to fight lung cancer that is resistant to other treatments.

| DelveInsight The dynamics of the acromegaly market are anticipated to change due to extensive R&D, the entry of novel therapies such as Debio 4126 (Debiopharm International SA), ALXN2420 ...

Please provide your email address to receive an email when new articles are posted on . The warnings related to CVD, breast cancer and probable dementia will be removed from six menopausal hormone ...

Boxed warnings were removed from Prometrium, Divigel, Cenestin, Enjuvia, Estring, and Bijuva, spanning progestogen-only, systemic estrogen-only, topical vaginal estrogen, and combined systemic ...

George Barreto receives funding from Research Ireland. Miguel G. Borda does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this ...

In a first-in-human study, researchers at The University of Texas MD Anderson Cancer Center observed strong responses and early signs of antitumor activity in patients with difficult-to-treat ...